×
Home
Archive Submission Guidelines
News Contact
Original article
Crossmark

EXPRESSION OF ANOCTAMIN-1 IN HUMAN GASTROINTESTINAL TRACT DURING EMBRYONIC AND FETAL DEVELOPMENT

By
Vladimir Petrovic Orcid logo ,
Vladimir Petrovic
Contact Vladimir Petrovic

Department of Histology and Embryology, Faculty of Medicine, University in Niš , Niš , Serbia

Aleksandra Veličkov Orcid logo ,
Aleksandra Veličkov

Department of Histology and Embryology, Faculty of Medicine, University in Niš , Niš , Serbia

Marko Jović Orcid logo ,
Marko Jović

Department of Histology and Embryology, Faculty of medicine, University in Niš , Niš , Serbia

Julija Radenković Orcid logo ,
Julija Radenković

Department of Pathology, Faculty of Medicine, University in Niš , Niš , Serbia

Braca Kundalić Orcid logo ,
Braca Kundalić

Department of Anatomy, Faculty of Medicine, University in Niš , Niš , Serbia

Dušan Miljković Orcid logo ,
Dušan Miljković

Clinic for Pediatrics, University Clinical Center Niš , Niš , Serbia

Vukota Radovanović Orcid logo ,
Vukota Radovanović

Department of Physical Medicine, Faculty of Medicine, University of Niš , Niš , Serbia

Goran Radenković Orcid logo
Goran Radenković

Department of Histology and Embryology, Faculty of Medicine, University in Niš , Niš , Serbia

Abstract

Anoctamin-1 (ANO1, TMEM16A), a transmembrane protein belonging to the ANO family, plays a role in the formation of calcium-activated chloride channels (CaCCs). It is involved in the regulation of physiological processes, including muscle contraction, gastrointestinal motility, secretion, and electrical excitability. Also, recent data suggest that ANO1 is a specific marker for interstitial cells of Cajal (ICC). The aim of the paper was to examine the spatial and temporal distribution of ANO1 in the human stomach, small intestine, and large intestine during embryo-fetal development as a potential marker for the differentiation of ICC and smooth muscle cells (SMCs). As a material, we used samples from 2 embryos and 21 fetuses. The tissue samples were routinely processed into paraffin blocks, and 5 µm-thick sections were immunostained for ANO1. Our results showed that ANO1 expression appeared during the 8th week of embryonic development and persisted through the fetal stages. Epithelial, endothelial, and ICC cells consistently expressed ANO1 in all examined samples. SMCs showed strong ANO1 expression in the muscularis propria; however, by the 25th week, this immunopositivity was absent from the outer muscle layers in the stomach and large intestine. In conclusion, ANO1 can be considered a reliable marker for tracking the differentiation of SMCs and ICC during embryonic and fetal development.

Author Contributions

Conceptualization, V.P. and G.R.; Formal Analysis, V.P.; Writing – original draft, V.P.; Writing – review & editing, A.V., M.J. and G.R.; Data curation, J.R. and G.R.; Methodology, B.K., D.M. and V.R.; Supervision, G.R. All authors have read and agreed to the published version of the manuscript.

Funding Statement

Research reported in this paper was supported by the Project number 451-03-137/2025-03/200113 of the Ministry of Science, Technological Development and Innovations of the Republic of Serbia and the Internal project of the Faculty of Medicine in Niš (INT-MFN no. 38/20).

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.